Sexually transmitted disease clinic · TX
NS3 Health
- 0Registered locations
- 1Associated locations
- 10Contract pharmacies
- 10With no end date
- 1 July 2026In 340B since
Finances, as filed
This entity type does not file a Medicare cost report; no finances are recorded.
Changes recorded
Nothing on this record has moved since it was first read here on 6 September 2026.
Cite this page
Velarion Records, “NS3 Health” (340B ID STD78727), citing the HRSA 340B OPAIS Covered Entity Daily Report, file 340B_CoveredEntity_Daily_20260907_110549.xlsx. https://velarionrecords.com/340b/STD78727
Register detail and identifiers
Participation, as filed
- Participating
- TRUE
- Participation start date
- 1 July 2026
- Record last edited
- 1 July 2026
Identifiers
- 340B ID
- STD78727
- Entity type as filed
- STD
- Grant number
- NU62PS924809
2209 W Parmer Lane, Austin TX 78727
Associated locations
| Organization | Address | Where |
|---|---|---|
| NS3 Health | 2209 W Parmer Lane | Austin TX 78727 |
Pharmacy contracts
| Pharmacy | Where | Begins | Ends |
|---|---|---|---|
| AVITA PHARMACY 1029 | SAN ANTONIO, TX | 1 July 2026 | no end date filed |
| AVITA PHARMACY 1034 | AUSTIN, TX | 1 July 2026 | no end date filed |
| AVITA PHARMACY 1035 | AUSTIN, TX | 1 July 2026 | no end date filed |
| AVITA PHARMACY 1036 | AUSTIN, TX | 1 July 2026 | no end date filed |
| AVITA PHARMACY 1040 | BATON ROUGE, LA | 1 July 2026 | no end date filed |
| KNU-HEALTH ATLANTA, INC. | ATLANTA, GA | 1 July 2026 | no end date filed |
| LONGS DRUGS OF LEXINGTON | LEXINGTON, SC | 1 July 2026 | no end date filed |
| WALGREEN CO. | AUSTIN, TX | 1 October 2026 | no end date filed |
| WALGREEN CO. | AUSTIN, TX | 1 October 2026 | no end date filed |
| Walgreens MFC #21373 | Northlake, TX | 1 October 2026 | no end date filed |
Every figure on this page is printed as it appears in the HRSA 340B OPAIS Covered Entity Daily Report, file 340B_CoveredEntity_Daily_20260907_110549.xlsx, stamped by its publisher 7 September 2026. This record has been read here since 6 September 2026.